Abstract

Tissue factor (TF) signalling has been associated with alterations in Akt activity influencing cellular survival and proliferation. TF is also shown to induce signalling through activation of the protease activated receptor (PAR)2. Seven cell lines were exposed to recombinant-TF (rec-TF), or activated using a PAR2-agonist peptide and the phosphorylation state of PTEN, and the activities of PTEN and Akt measured. Furthermore, by measuring the association of PTEN with MAGI proteins a mechanism for the induction of signalling by TF was proposed. Short term treatment of cells resulted in de-phosphorylation of PTEN, increased lipid-phosphatase activity and reduced Akt kinase activity in most of the cell lines examined. In contrast, continuous exposure to rec-TF up to 14 days, resulted in lower PTEN antigen levels, enhanced Akt activity and increased rate of cell proliferation. To explore the mechanism of activation of PTEN by TF, the association of "membrane-associated guanylate kinase-with inverted configuration" (MAGI)1–3 proteins with PTEN was assessed using the proximity ligation assay and by co-immunoprecipitation. The interaction of PTEN with all three MAGI proteins was transiently reduced following PAR2 activation and explains the changes in PTEN activity. Our data is first to show that PAR2 activation directly, or through exposure of cells to TF releases PTEN from MAGI proteins and is concurrent with increases in PTEN phosphatase activity. However, prolonged exposure to TF results in the reduction in PTEN antigen with concurrent increase in Akt activity which may explain the aberrant cell survival, proliferation and invasion associated with TF during chronic diseases.

Highlights

  • Abbreviations TF Tissue factor factor VIIa (fVIIa)/Xa Factor VIIa/fXa PTEN Phosphatase and tensin homolog protein PI3K Phosphoinositol-3-kinase PIP3 Phosphoinositol-3-phosphate membrane-associated guanylate kinase with inverted configuration (MAGI) Membrane-associated guanylate kinase-with inverted configuration PAR2 Protease activated receptor 2

  • Of particular interest is the ability of TF to confer improved survival in cancer cells, and a notable mechanism has been the activation of Akt pathway following the association of TF with factor ­VII11–16

  • We monitored PTEN and Akt activities in seven cancer cell lines in the short-term following a single treatment with rec-TF or PAR2-agonist peptide (PAR2-AP), as well as examining the outcome of exposure of cells to repeated doses of TF over longer periods

Read more

Summary

Introduction

Abbreviations TF Tissue factor fVIIa/Xa Factor VIIa/fXa PTEN Phosphatase and tensin homolog protein PI3K Phosphoinositol-3-kinase PIP3 Phosphoinositol-3-phosphate MAGI Membrane-associated guanylate kinase-with inverted configuration PAR2 Protease activated receptor 2. The loss of PTEN through mutational inactivation has been strongly associated with many c­ ancers[25,26,27,28] These alterations have been identified as markers of the severity of the progression of ­cancer[29,30,31,32], as well as the aberrant formation of tissue and ­tumourgenesis[33,34]. MAGI proteins have been implicated in the control of cell migration and invasion through altering the activity of PTEN and modulating Akt ­signalling[51,52,53,54]. It is known that the de-phosphorylation of PTEN accelerates its degradation and can moderate the total amount of PTEN within the c­ ell[53]

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call